+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID07025824

Randomized Comparison of Treosulfan Versus Melphalan Conditioning Chemotherapy with Post-Transplant Cyclophosphamide in Adults with AML and MDS Undergoing Allogeneic Stem Cell Transplantation

Led by Technische Universität Dresden · Updated on 2026-09-02

220

Participants Needed

17

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are comparing the effects and tolerability of two chemotherapy conditioning treatments, Treosulfan and Melphalan, given before allogeneic stem cell transplantation in patients with Acute Myeloid Leukemia AML and Myelodysplastic Syndrome MDS. The study also looks at survival rates, remission and relapse, graft success or failure, and occurrences of Graft versus Host Disease GvHD. Participants receive either Treosulfan combined with Fludarabine from day -6 to day -2 or Melphalan combined with Fludarabine over the same period before transplantation. Both treatments are given intravenously, with specific dosing schedules Treosulfan at 10 gm2 on days -4 to -2, Melphalan at 140 mgm2 on day -2, and Fludarabine at 30 mgm2 from day -6 to day -2. GvHD prevention is planned with post-transplant cyclophosphamide PTCy on days 3 and 4. During the study, participants are monitored for overall survival up to two years after randomization. Researchers also assess relapse-free survival, non-relapse mortality, acute and chronic GvHD incidence, adverse events within 56 days post-transplant, engraftment rates, and remission status. Follow-up includes clinical and laboratory evaluations to understand treatment impact and safety over time.

CONDITIONS

Brief Title

Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation

Research Team

P

Prof. Friedrich Stölzel, MD

D

Desiree Kunadt, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here